Launched last July, babyLance™ heel incision devices are a safe, easy and effective solution for neonatal caregivers to collect blood samples from infants.
MED Alliance Group will be distributing two models from the babyLance™ line:
• The babyLance™ Newborn (BLN), which delivers an incision depth of 1.00 mm.
• The babyLance™ Preemie (BLP), which delivers an incision depth of 0.85 mm.
“We are supremely delighted that MED Alliance Group will be distributing our medical products,” said MediPurpose President Randy Prather. “We are particularly impressed by their commitment to quality and their efforts to meet both customers’ and regulatory requirements.”
MediPurpose invites healthcare professionals to request no-cost samples of babyLance™ heel incision devices. Visit their Website at http://www.medipurpose.com/
About MED Alliance Group
Based in St. Charles, Illinois, MED Alliance Group has more than 350 years of combined medical device sales and distribution experience.
MED Alliance Group’s strategy is to offer suppliers and customers a premium, customized sales and distribution solution. As an ISO 13485:2003 certified organization, MED Alliance Group embraces quality and is always looking for ways to improve.
For more information about MED Alliance Group, please visit http://www.medalliancegroup.com.
# # #
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’